Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2020

14.02.2020 | Current Clinical Controversy

Liver Transplantation for Alcoholic Liver Disease: What Is the Risk and Consequence of Relapse?

verfasst von: James Neuberger

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Although short- and medium-term outcomes after liver transplantation for alcohol-related liver disease (ARLD) are generally excellent and similar to outcomes for transplantation for other indications, a return to alcohol consumption commonly occurs even though rates of alcohol consumption after transplantation for ARLD are comparable to those seen in other indications. Transplant recipients should be questioned about alcohol use post-transplantation and, where appropriate, monitored; those drinking significant amounts should be offered treatment with the help of a multi-disciplinary team. Although short-term significant alcohol use is associated with an increased risk of non-compliance and rejection, medium-term outcomes are similar to other groups. Patients transplanted for ARLD have a greater risk of some de novo malignancies, especially of the lung and the upper GI tract. More work is required both to identify those at risk of a return to destructive patterns of alcohol use at an early stage and to develop effective treatments aimed at reaching and maintaining abstinence.
Literatur
1.
Zurück zum Zitat Starzl TE, Van Thiel D, Tzakis AG, et al. Orthotopic liver transplantation for alcoholic cirrhosis. JAMA. 1988;260:2542–2544.CrossRef Starzl TE, Van Thiel D, Tzakis AG, et al. Orthotopic liver transplantation for alcoholic cirrhosis. JAMA. 1988;260:2542–2544.CrossRef
2.
Zurück zum Zitat Giard JM, Dodge JL, Terrault NA. Superior wait-list outcomes in patients with alcohol-associated liver disease compared with other indications for liver transplantation. Liver Transpl. 2019;25:1310–1320.CrossRef Giard JM, Dodge JL, Terrault NA. Superior wait-list outcomes in patients with alcohol-associated liver disease compared with other indications for liver transplantation. Liver Transpl. 2019;25:1310–1320.CrossRef
3.
Zurück zum Zitat Neuberger J. Public and professional attitudes to transplanting alcoholic patients. Liver Transpl. 2007;13:S65–S68.CrossRef Neuberger J. Public and professional attitudes to transplanting alcoholic patients. Liver Transpl. 2007;13:S65–S68.CrossRef
4.
Zurück zum Zitat Mathurin P, Lucey MR. Alcohol, liver disease, and transplantation: shifting attitudes and new understanding leads to changes in practice. Curr Opin Org Transpl. 2018;23:175–179.CrossRef Mathurin P, Lucey MR. Alcohol, liver disease, and transplantation: shifting attitudes and new understanding leads to changes in practice. Curr Opin Org Transpl. 2018;23:175–179.CrossRef
5.
Zurück zum Zitat Lucey MR. Liver transplantation for alcoholic liver disease: past, present, and future. Liver Transpl. 2007;13:190–192.CrossRef Lucey MR. Liver transplantation for alcoholic liver disease: past, present, and future. Liver Transpl. 2007;13:190–192.CrossRef
7.
Zurück zum Zitat Yates WR, Booth BM, Reed DA, Brown K, Masterson BJ. Descriptive and predictive validity of a high-risk alcoholism relapse model. J Stud Alcohol. 1993;54:645–651.CrossRef Yates WR, Booth BM, Reed DA, Brown K, Masterson BJ. Descriptive and predictive validity of a high-risk alcoholism relapse model. J Stud Alcohol. 1993;54:645–651.CrossRef
8.
Zurück zum Zitat De Gottardi A, Spahr L, Gelez P, et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med. 2007;167:1183–1188.CrossRef De Gottardi A, Spahr L, Gelez P, et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med. 2007;167:1183–1188.CrossRef
9.
Zurück zum Zitat Rodrigue JR, Hanto DW, Curry MP. The alcohol relapse risk assessment: a scoring system to predict the risk of relapse to any alcohol use after LT. Prog Transpl. 2013;23:310–318.CrossRef Rodrigue JR, Hanto DW, Curry MP. The alcohol relapse risk assessment: a scoring system to predict the risk of relapse to any alcohol use after LT. Prog Transpl. 2013;23:310–318.CrossRef
10.
Zurück zum Zitat Maldonado JR, Dubois HC, David EE, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53:123–132.CrossRef Maldonado JR, Dubois HC, David EE, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53:123–132.CrossRef
11.
Zurück zum Zitat Lee BP, Vittinghoff E, Hsu C, et al. Predicting low risk for sustained alcohol use after early LT for acute alcoholic hepatitis: the sustained alcohol use post-LT score. Hepatology. 2019;69:1477–1487.CrossRef Lee BP, Vittinghoff E, Hsu C, et al. Predicting low risk for sustained alcohol use after early LT for acute alcoholic hepatitis: the sustained alcohol use post-LT score. Hepatology. 2019;69:1477–1487.CrossRef
12.
Zurück zum Zitat Donnadieu-Rigole H, Perney P, Ursic-Bedoya J, Faure S, Pageaux GP. Addictive behaviors in LT recipients: the real problem? World J Hepatol. 2017;9:953–958.CrossRef Donnadieu-Rigole H, Perney P, Ursic-Bedoya J, Faure S, Pageaux GP. Addictive behaviors in LT recipients: the real problem? World J Hepatol. 2017;9:953–958.CrossRef
14.
Zurück zum Zitat DiMartini A, Dew MA, Day N, et al. Trajectories of alcohol consumption following liver transplantation. Am J Transpl. 2010;10:2305–2312.CrossRef DiMartini A, Dew MA, Day N, et al. Trajectories of alcohol consumption following liver transplantation. Am J Transpl. 2010;10:2305–2312.CrossRef
15.
Zurück zum Zitat Lim J, Curry MP, Sundaram V. Risk factors and outcomes associated with alcohol relapse after liver transplantation. World J Hepatol. 2017;9:771–780.CrossRef Lim J, Curry MP, Sundaram V. Risk factors and outcomes associated with alcohol relapse after liver transplantation. World J Hepatol. 2017;9:771–780.CrossRef
16.
Zurück zum Zitat Nickels M, Jain A, Sharma R, et al. Polysubstance abuse in liver transplant patients and its impact on survival outcome. Exp Clin Transpl. 2007;5:680–685. Nickels M, Jain A, Sharma R, et al. Polysubstance abuse in liver transplant patients and its impact on survival outcome. Exp Clin Transpl. 2007;5:680–685.
17.
Zurück zum Zitat Rogal S, Shenai N, Kruckenberg K, Rosenberger E, Dew MA, DiMartini A. Post-transplant outcomes of persons receiving a liver graft for alcoholic liver disease. Alcohol Alcohol. 2018;53:157–165.CrossRef Rogal S, Shenai N, Kruckenberg K, Rosenberger E, Dew MA, DiMartini A. Post-transplant outcomes of persons receiving a liver graft for alcoholic liver disease. Alcohol Alcohol. 2018;53:157–165.CrossRef
18.
Zurück zum Zitat DiMartini A, Javed L, Russell S, et al. Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl. 2005;11:679–683.CrossRef DiMartini A, Javed L, Russell S, et al. Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl. 2005;11:679–683.CrossRef
19.
Zurück zum Zitat Russ KB, Chen NW, Kamath PS, Shah VH, Kuo YF, Singal AK. Alcohol use after liver transplantation is independent of liver disease etiology. Alcohol Alcohol. 2016;51:698–701.CrossRef Russ KB, Chen NW, Kamath PS, Shah VH, Kuo YF, Singal AK. Alcohol use after liver transplantation is independent of liver disease etiology. Alcohol Alcohol. 2016;51:698–701.CrossRef
20.
Zurück zum Zitat Koljonen V, Åberg F, Rovasalo A, Mäkisalo H. Self-reported alcohol use and depressive symptoms after liver transplantation. Transplantation. 2015;99:867–872.CrossRef Koljonen V, Åberg F, Rovasalo A, Mäkisalo H. Self-reported alcohol use and depressive symptoms after liver transplantation. Transplantation. 2015;99:867–872.CrossRef
21.
Zurück zum Zitat Ursic-Bedoya J, Donnadieu-Rigole H, Faure S, Pageaux GP. The influence of alcohol use on outcomes in patients transplanted for nonalcoholic liver disease. Alcohol Alcohol. 2018;53:184–186.CrossRef Ursic-Bedoya J, Donnadieu-Rigole H, Faure S, Pageaux GP. The influence of alcohol use on outcomes in patients transplanted for nonalcoholic liver disease. Alcohol Alcohol. 2018;53:184–186.CrossRef
22.
Zurück zum Zitat Parker R, Armstrong MJ, Corbett C, Day EJ, Neuberger JM. Alcohol and substance abuse in solid-organ transplant recipients. Transplantation. 2013;96:1015–1024.CrossRef Parker R, Armstrong MJ, Corbett C, Day EJ, Neuberger JM. Alcohol and substance abuse in solid-organ transplant recipients. Transplantation. 2013;96:1015–1024.CrossRef
23.
Zurück zum Zitat Dobbels F, Denhaerynck K, Klem ML, et al. Correlates and outcomes of alcohol use after single solid organ transplantation: a systematic review and meta-analysis. Transpl Rev (Orlando). 2019;33:17–28.CrossRef Dobbels F, Denhaerynck K, Klem ML, et al. Correlates and outcomes of alcohol use after single solid organ transplantation: a systematic review and meta-analysis. Transpl Rev (Orlando). 2019;33:17–28.CrossRef
24.
Zurück zum Zitat Shen NT, Londono C, Gold S, Wu A, Mages KC, Brown RSJ. Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes. World J Gastroenterol. 2019;25:1628–1639.CrossRef Shen NT, Londono C, Gold S, Wu A, Mages KC, Brown RSJ. Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes. World J Gastroenterol. 2019;25:1628–1639.CrossRef
25.
Zurück zum Zitat Burra P, Senzolo M, Adam R, et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transpl. 2010;10:138–148.CrossRef Burra P, Senzolo M, Adam R, et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transpl. 2010;10:138–148.CrossRef
26.
Zurück zum Zitat Huang Y, Joseph J, de Boer WB, et al. Long-term liver-related outcomes of patients with chronic liver diseases in Australia. Clin Gastroenterol Hepatol. 2019. pii: S1542-3565(19)30746-3. Huang Y, Joseph J, de Boer WB, et al. Long-term liver-related outcomes of patients with chronic liver diseases in Australia. Clin Gastroenterol Hepatol. 2019. pii: S1542-3565(19)30746-3.
27.
Zurück zum Zitat Kwong A, Kim WR, Lake JR et al. OPTN/SRTR 2018 Annual Data Report: Liver. Am J Transplant 2020;20(suppl s1):193–299.CrossRef Kwong A, Kim WR, Lake JR et al. OPTN/SRTR 2018 Annual Data Report: Liver. Am J Transplant 2020;20(suppl s1):193–299.CrossRef
28.
Zurück zum Zitat Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-LT: results of the NIDDK long-term follow-up study. Am J Transpl. 2010;10:1420–1427.CrossRef Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-LT: results of the NIDDK long-term follow-up study. Am J Transpl. 2010;10:1420–1427.CrossRef
30.
Zurück zum Zitat Mukthinuthalapati PK, Gotur R, Ghabril M. Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol. 2016;8:533–544.CrossRef Mukthinuthalapati PK, Gotur R, Ghabril M. Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol. 2016;8:533–544.CrossRef
31.
Zurück zum Zitat Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry. Br J Surg. 2014;101:768–774.CrossRef Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry. Br J Surg. 2014;101:768–774.CrossRef
32.
Zurück zum Zitat Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;10:1790–1800.CrossRef Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;10:1790–1800.CrossRef
33.
Zurück zum Zitat Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol. 2019;70:328–334.CrossRef Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol. 2019;70:328–334.CrossRef
34.
Zurück zum Zitat Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology. 2012;55:1398–1405.CrossRef Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology. 2012;55:1398–1405.CrossRef
35.
Zurück zum Zitat Lee BP, Mehta N, Platt L, et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology. 2018;155:422–430.CrossRef Lee BP, Mehta N, Platt L, et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology. 2018;155:422–430.CrossRef
36.
Zurück zum Zitat Al-Saeedi M, Barout MH, Probst P, et al. Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis. Langenbecks Arch Surg. 2018;403:825–836.CrossRef Al-Saeedi M, Barout MH, Probst P, et al. Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis. Langenbecks Arch Surg. 2018;403:825–836.CrossRef
37.
Zurück zum Zitat Lee BP, Terrault NA. Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transpl. 2018;23:229–236.CrossRef Lee BP, Terrault NA. Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transpl. 2018;23:229–236.CrossRef
38.
Zurück zum Zitat Marot A, Dubois M, Trépo E, Moreno C, Deltenre P. Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis. PLoS ONE. 2018;13:e0190823.CrossRef Marot A, Dubois M, Trépo E, Moreno C, Deltenre P. Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis. PLoS ONE. 2018;13:e0190823.CrossRef
39.
Zurück zum Zitat Lee BP, Samur S, Dalgic OO, et al. Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis. Gastroenterology. 2019;157:472–480.CrossRef Lee BP, Samur S, Dalgic OO, et al. Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis. Gastroenterology. 2019;157:472–480.CrossRef
44.
Zurück zum Zitat Kodali S, Kaif M, Tariq R, Singal AK. Alcohol relapse after liver transplantation for alcoholic cirrhosis-impact on liver graft and patient survival: a meta-analysis. Alcohol Alcohol. 2018;53:166–172.CrossRef Kodali S, Kaif M, Tariq R, Singal AK. Alcohol relapse after liver transplantation for alcoholic cirrhosis-impact on liver graft and patient survival: a meta-analysis. Alcohol Alcohol. 2018;53:166–172.CrossRef
45.
Zurück zum Zitat Erard-Poinsot D, Dharancy S, Hilleret MN, et al. Natural history of recurrent alcohol-related cirrhosis after liver transplantation: fast and furious. Liver Transpl. 2020;26:25–33.CrossRef Erard-Poinsot D, Dharancy S, Hilleret MN, et al. Natural history of recurrent alcohol-related cirrhosis after liver transplantation: fast and furious. Liver Transpl. 2020;26:25–33.CrossRef
46.
Zurück zum Zitat Magistri P, Marzi L, Guerzoni S, et al. Impact of a multidisciplinary team on alcohol recidivism and survival after LT for alcoholic disease. Transpl Proc. 2019;51:187–189.CrossRef Magistri P, Marzi L, Guerzoni S, et al. Impact of a multidisciplinary team on alcohol recidivism and survival after LT for alcoholic disease. Transpl Proc. 2019;51:187–189.CrossRef
Metadaten
Titel
Liver Transplantation for Alcoholic Liver Disease: What Is the Risk and Consequence of Relapse?
verfasst von
James Neuberger
Publikationsdatum
14.02.2020
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06127-3

Weitere Artikel der Ausgabe 6/2020

Digestive Diseases and Sciences 6/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.